Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007
Published online before print June 7, 2007, doi: 10.1161/CIRCRESAHA.107.148379
A more recent version of this article appeared on July 20, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v101,pe80)
Right arrow All Versions of this Article:
101/2/205    most recent
CIRCRESAHA.107.148379v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rajan, S.
Right arrow Articles by Wieczorek, D. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rajan, S.
Right arrow Articles by Wieczorek, D. F.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*Protein*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
Medline Plus Health Information
*Cardiomyopathy
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease
Right arrow Heart failure - basic studies
Right arrow Myocardial cardiomyopathy disease

Submitted on January 10, 2007
Revised on May 22, 2007
Accepted on May 24, 2007

Dilated Cardiomyopathy Mutant Tropomyosin Mice Develop Cardiac Dysfunction With Significantly Decreased Fractional Shortening and Myofilament Calcium Sensitivity

Sudarsan Rajan ; Rafeeq P.H. Ahmed ; Ganapathy Jagatheesan ; Natalia Petrashevskaya ; Greg P. Boivin ; Dalia Urboniene ; Grace M. Arteaga ; Beata M. Wolska ; R. John Solaro ; Stephen B. Liggett ; and David F. Wieczorek *

From the Department of Molecular Genetics, Biochemistry, and Microbiology (S.R., R.P.H.A., G.J., D.F.W.), University of Cincinnati Medical Center, Cincinnati, Ohio; Department of Pathology and Laboratory Medicine (G.P.B.), University of Cincinnati Medical Center, Ohio; Department of Physiology and Biophysics (D.U., G.M.A., B.M.W., R.J.S.), University of Illinois, Chicago College of Medicine; and Department of Medicine (N.P., S.B.L.), University of Maryland, Baltimore.

* To whom correspondence should be addressed. E-mail: David.Wieczorek{at}uc.edu.

Mutations in striated muscle {alpha}-tropomyosin ({alpha}-TM), an essential thin filament protein, cause both dilated cardiomyopathy (DCM) and familial hypertrophic cardiomyopathy. Two distinct point mutations within {alpha}-tropomyosin are associated with the development of DCM in humans: Glu40Lys and Glu54Lys. To investigate the functional consequences of {alpha}-TM mutations associated with DCM, we generated transgenic mice that express mutant {alpha}-TM (Glu54Lys) in the adult heart. Results showed that an increase in transgenic protein expression led to a reciprocal decrease in endogenous {alpha}-TM levels, with total myofilament TM protein levels remaining unaltered. Histological and morphological analyses revealed development of DCM with progression to heart failure and frequently death by 6 months. Echocardiographic analyses confirmed the dilated phenotype of the heart with a significant decrease in the left ventricular fractional shortening. Work-performing heart analyses showed significantly impaired systolic, and diastolic functions and the force measurements of cardiac myofibers revealed that the myofilaments had significantly decreased Ca2+ sensitivity and tension generation. Real-time RT-PCR quantification demonstrated an increased expression of {beta}-myosin heavy chain, bone natriuretic peptide, and skeletal actin and a decreased expression of the Ca2+ handling proteins sarcoplasmic reticulum Ca2+-ATPase and ryanodine receptor. Furthermore, our study also indicates that the {alpha}-TM54 mutation decreases tropomyosin flexibility, which may influence actin binding and myofilament Ca2+ sensitivity. The pathological and physiological phenotypes exhibited by these mice are consistent with those seen in human DCM and heart failure. As such, this is the first mouse model in which a mutation in a sarcomeric thin filament protein, specifically TM, leads to DCM.
Key words: mouse model • transgenic • myocardial contractility • thin filament




This article has been cited by other articles:


Home page
 J. Appl. Physiol.Home page
J. Naghshin, K. R. McGaffin, W. G. Witham, M. A. Mathier, L. C. Romano, S. H. Smith, A. M. Janczewski, J. A. Kirk, S. G. Shroff, and C. P. O'Donnell
Chronic intermittent hypoxia increases left ventricular contractility in C57BL/6J mice
J Appl Physiol, September 1, 2009; 107(3): 787 - 793.
[Abstract] [Full Text] [PDF]

Home page
 Circ Heart FailHome page
E. C. Dyer, A. M. Jacques, A. C. Hoskins, D. G. Ward, C. E. Gallon, A. E. Messer, J. P. Kaski, M. Burch, J. C. Kentish, and S. B. Marston
Functional Analysis of a Unique Troponin C Mutation, GLY159ASP, that Causes Familial Dilated Cardiomyopathy, Studied in Explanted Heart Muscle
Circ Heart Fail, September 1, 2009; 2(5): 456 - 464.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
S. Morimoto
Expanded Spectrum of Gene Causing Both Hypertrophic Cardiomyopathy and Dilated Cardiomyopathy
Circ. Res., August 14, 2009; 105(4): 313 - 315.
[Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
L. Mestroni
Phenotypic heterogeneity of sarcomeric gene mutations: a matter of gain and loss?
J. Am. Coll. Cardiol., July 21, 2009; 54(4): 343 - 345.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
G. Jagatheesan, S. Rajan, E. M. Schulz, R. P. H. Ahmed, N. Petrashevskaya, A. Schwartz, G. P. Boivin, G. M. Arteaga, T. Wang, Y.-G. Wang, et al.
An internal domain of {beta}-tropomyosin increases myofilament Ca2+ sensitivity
Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H181 - H190.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Dweck, N. Hus, and J. D. Potter
Challenging Current Paradigms Related to Cardiomyopathies: ARE CHANGES IN THE Ca2+ SENSITIVITY OF MYOFILAMENTS CONTAINING CARDIAC TROPONIN C MUTATIONS (G159D AND L29Q) GOOD PREDICTORS OF THE PHENOTYPIC OUTCOMES?
J. Biol. Chem., November 28, 2008; 283(48): 33119 - 33128.
[Abstract] [Full Text] [PDF]

Home page
 Cardiovasc ResHome page
S. Morimoto
Sarcomeric proteins and inherited cardiomyopathies
Cardiovasc Res, March 1, 2008; 77(4): 659 - 666.
[Abstract] [Full Text] [PDF]


Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.